BPI-572270

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPI-572270, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 1, Phase 2]